NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
HorizonFRAMEWORKSME SUITABLEScore 83/100
- Buyer
- NHS England
- Current holder
- Upgrade to see
- Contract value
- £665,389,588
- Contract ends
- 31 Aug 2028 (664 days)
- Re-tender likely opens
- Upgrade to see
- Category
- goods
- CPV codes
- 33600000
Why it scores 83
- Value35
- Timing17
- Unclaimed15
- Recurrence12
- Access4
Nothing from this buyer since the window opened reads as its replacement, so it does not appear to have gone back out yet.
How contested is this?
Buyers publish how many bids they received. Across 61 comparable procurements we can tell you the typical field size, how often one of these goes uncontested, and whether the buyer awards on price or on quality.
Notice history
6 events · 6 releases on Find a Tender
- Pipeline or early engagement notice13 Jan 2026, 09:57 GMT002508-2026
- Notice published13 Mar 2026, 15:08 GMT023102-2026
- Tender notice17 Mar 2026, 12:14 GMT023990-2026
- Award decision published23 Jun 2026, 12:33 BST058925-2026
- Award updated9 Jul 2026, 15:45 BST064847-2026
- Award decision published21 Jul 2026, 11:16 BST068603-2026